TRT and Gynecomastia: How Common It Is, Why It Happens, and What Actually Works

TRT and gynecomastia can be linked: testosterone treatment can cause breast gland growth, but nipple tenderness alone does not confirm it. Selected gel-label trials reported 0–3% across treatment groups—not a risk estimate for every form of TRT. A new lump or nipple change needs assessment before you change treatment or add an estrogen blocker. ^{1, 3, 28}

By TRT Provider Guide · Last verified October 2026 · Editorial research, not clinically reviewed

Last updated: October 5, 2026.

Educational information, not medical advice. Contact a clinician promptly about a new breast lump, nipple discharge, a nipple pulling inward, or skin changes. ²⁸

Best for: adult men using or considering prescribed TRT for testosterone deficiency. Not for: diagnosing a lump, choosing a dose, or self-treating; adolescent, gender-affirming, and nonmedical hormone use need their own care framework.

Here's the catch with the "estrogen blocker" people often hear about, anastrozole: it didn't beat placebo in the gynecomastia trial described on its FDA label, but that trial involved boys in puberty—not adult men on TRT. Tamoxifen has stronger evidence in other settings, not proof that it will fix TRT-related breast growth. We'll get to both. ^{17, 22, 25}

What changes the answer for you:

• How long it's been there. Recent, tender swelling has options. Firm tissue that's been there many months usually doesn't shrink with medicine. ^{22, 23}
• What it actually is. Gland tissue, chest fat, and a lump that needs checking are three different things.
• Any red-flag signs. A hard, fixed lump, nipple discharge, a nipple pulling inward, skin dimpling, or a lump in your armpit means contacting a clinician promptly, not "wait and see." ²⁸

What you're noticing — and what to do about it

This table is a guide to the next conversation. It can't tell you what a lump is. Assessment may require an exam, imaging, or a biopsy—not a photograph or a hormone number. ^{22, 24, 28}

Jump to the printable appointment worksheet ↓ — a couple of minutes to fill out, and it makes your visit far more useful.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

---

TRT and gynecomastia: what do the product labels show?

Yes: all 16 testosterone label records in this comparison recognize gynecomastia, and several warn that it can persist. Selected gel trials reported 0–3% across treatment groups; those figures do not establish a rate for all TRT products or predict your risk. A warning without a percentage is not evidence of zero risk. ^{1, 3, 7}

First, the plain definition. Gynecomastia is growth of breast gland tissue in a man. It usually feels like a firm or rubbery disc sitting right under the nipple. It isn't the same as chest fat. ²⁴

We wanted the actual numbers. So on October 5, 2026, we compared 16 testosterone product label records, one by one. Here's what they say.

This is a label-evidence comparison, not a list of products currently available to prescribe. Fortesta and Androderm are represented by the archived labels identified below; their historical warnings are not presented as current prescribing information.

What 16 testosterone label records say about gynecomastia

Source records checked October 5, 2026. "None given" means no numerical gynecomastia incidence in the cited sections—not that no cases occurred. Label versions and study populations are kept separate.

What the table tells you (and what it doesn't)

Four things stand out:

1. Every label in this comparison recognizes it. You're not imagining an internet myth. Gynecomastia is a labeled effect of testosterone treatment.
2. The reported numbers were small in these gel trials. Treatment-group rates ran 0–3%. The Testim and Vogelxo label tables report 0% in their placebo group; the AndroGel 1% 180-day comparison was not placebo-controlled. ^{1, 3, 4}
3. Two labels retain the word "frequently." The Hikma enanthate and Testopel labels use that word but give no number. It remains in their 2025 revisions. These label tables do not provide a head-to-head comparison that can rank which treatment format is "safest" for your chest. ^{8, 9}
4. Compounded testosterone is not FDA-approved. Compounded creams, troches, and injections do not have an FDA-reviewed product-specific trial estimate in this comparison. That does not prove no research exists, and the commercial gel rates above cannot be assigned to a compounded preparation. ³¹

One more honest caution: don't add these numbers together or average them. Studies differ in length and participants, and some labels repeat the same data. Breast pain was also tracked separately from gynecomastia, so a sore nipple isn't automatically gland growth. ^{1, 3, 4}

---

Is it gynecomastia, chest fat, or something that needs a doctor now?

Gynecomastia often feels like a firm or rubbery disc of gland tissue centered under the nipple, on one or both sides, and can be tender. Chest fat is softer and spread out, but feel alone cannot establish the diagnosis. A hard lump that's off to one side, doesn't move, or comes with nipple discharge, a nipple turning inward, skin changes, or an armpit lump needs a prompt exam. ^{22, 24, 28}

It's normal to be worried here. One man on Reddit's r/trt community put it plainly: "I just don't want it to fully form then I'm either stuck with it or will need surgery." That fear is reasonable — and it's why the first job is figuring out what you're actually dealing with. This is one reader's concern, not evidence of a treatment result.

Three things that look alike

Looks and touch are clues, not a diagnosis. A clinician's exam helps tell these apart; unclear or suspicious findings may need imaging or a biopsy. ^{22, 28}

How worried should you be about cancer?

Breast cancer in men is rare. The American Cancer Society expects about 2,670 new cases of invasive breast cancer in U.S. men in 2026. Men account for under 1% of all breast cancers, and a man's lifetime risk is about 1 in 755. ²⁹

Rare isn't zero, though. The National Cancer Institute lists these signs to get checked: ²⁸

• A lump or thickening in or near the breast (the most common sign)
• A nipple that changes shape or direction, or turns inward
• Clear or bloody fluid from the nipple
• An open sore on the breast skin
• Scaly, red, or swollen skin on the breast, nipple, or areola
• Dimpled skin that looks like an orange peel
• Swollen lymph nodes under the arm or near the collarbone

The testosterone labels checked list breast cancer in men as a reason not to use testosterone. That's why a suspicious lump comes before any talk about doses, blood tests, or estrogen blockers. ^{1, 7, 20}

---

Why does testosterone cause breast growth?

Your body turns some testosterone into estradiol, a form of estrogen, using an enzyme called aromatase. Gland growth can occur when estrogen's effects on breast tissue outweigh androgen effects. Testosterone treatment can raise estradiol, but that does not mean every rise causes gynecomastia. ^{1, 22}

Think of it like a seesaw. Testosterone sits on one side, estrogen on the other. Breast tissue responds when the estrogen side pushes harder. It's an explanation of the signals—not a lab ratio you can use to diagnose yourself. ²²

The labels confirm estradiol can go up on treatment. On AndroGel 1%, average estradiol rose within 30 days but stayed in the normal range for men. On Aveed, "estradiol increased" is listed as a side effect. Neither observation tells you when a breast lump will appear. ^{1, 11}

The twist: low testosterone can cause it too

The Endocrine Society's testosterone guideline lists breast discomfort and gynecomastia as signs that can point to low testosterone. Breast tissue can therefore be present before TRT, rather than caused by it. ²⁰

That's why the American Urological Association says estradiol should be measured before starting TRT in men who already have breast symptoms or gynecomastia. If that's you and you haven't started yet, ask about that test and a breast exam. ²¹

Breast growth alone does not diagnose low testosterone. Diagnosis requires compatible symptoms or signs plus consistently low testosterone on reliable testing, confirmed with separate early-morning measurements. The Endocrine Society recommends fasting morning testing. One result, one cutoff, or a questionnaire is not enough. ^{20, 21}

TRT isn't the only suspect

Timing makes TRT an obvious suspect, but timing isn't proof. Certain medicines and health problems — such as liver, kidney, or thyroid conditions — can also cause breast growth. Nonmedical anabolic-steroid use can also contribute. Tell your clinician about everything you take, including supplements. ^{22, 24}

---

Will gynecomastia from TRT go away?

Sometimes: recent gynecomastia may settle after the cause is addressed, but recovery is not guaranteed. Long-standing tissue can become fibrous — more like scar tissue — and respond poorly to medicine. Duration helps guide the discussion, but there is no fixed month when every case becomes permanent. ^{22, 23}

Here's how the tissue changes over time:

The 2026 SIAMS guideline notes that regression becomes less likely after about six months in secondary gynecomastia, but also acknowledges uncertainty about observation periods. That is not a precise deadline, and your body won't read a calendar either. ²³

So here's the one honest reason not to wait: early assessment can keep you from treating the wrong cause. It does not mean you must rush into a new medicine or surgery. After a cause has been addressed, your clinician may recommend observation. ^{22, 23}

A note on the word "transient." Breast symptoms during TRT can abate, but the product labels also say gynecomastia may persist. Do not read either statement as a promise about your outcome. ^{1, 3, 21}

---

What should you do first if you notice breast changes on TRT?

Don't stop or change your testosterone on your own, and don't start an "estrogen blocker" you bought online. Contact your prescriber, describe what changed and when, and ask for an exam. If you have any red-flag sign, contact a clinician promptly — even if that's not your TRT clinic. ^{1, 22, 28}

Six steps, in order:

1. Write down what you see. Which side, when you first noticed it, sore or not, any fluid from the nipple. Dated photos for your own records help.
2. Write down your TRT timeline. When you started, what you take, and the date of any dose or format change.
3. Book your prescriber. If your clinic is online-only and can't examine you, see a primary care doctor in person for the exam.
4. Ask what tests make sense. An estradiol blood test may be useful, but it's one piece. Ask how the timing of the draw relates to your last dose, so results can be compared over time. ^{20, 21}
5. Ask about options in order. Assessment of the cause comes first, including a review of your testosterone plan. Observation or added medicine may fit some cases; a surgery referral may fit persistent, bothersome tissue. ^{22, 23}
6. Don't self-treat. Testosterone is a Schedule III controlled substance in the U.S. — a prescription drug with extra federal rules. Changes to it belong with your prescriber. ^{1, 30}

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

Is your current clinic not set up to examine you or follow up on this? Arrange the breast exam first. Find My TRT Path can then help organize broader care-route questions about testing, fertility, insurance, budget, and online or local care. It's educational and doesn't diagnose anything or determine medical eligibility.

Explore care routes with Find My TRT Path →

---

What tests might a clinician use — and what estradiol level causes gyno?

Assessment starts with your history and a hands-on exam. A clinician may add blood tests, such as estradiol and testosterone, and sometimes imaging. There is no validated estradiol cutoff that diagnoses gynecomastia, and a blood test can't tell what a lump is. ^{22, 23, 24}

What the exam and history add

Your clinician will want to know when it started, whether it's one side or both, what medicines you take, and whether you've had breast changes before. The exam helps distinguish gland from fat and checks for anything that needs imaging. If something looks suspicious, they may order an ultrasound or mammogram; some findings need a biopsy. ^{22, 28}

Depending on the findings, assessment may also include a testicular exam and tests for other hormone, thyroid, liver, or kidney causes. Not everyone needs every test, and a typical clinical finding does not automatically require breast imaging. ^{22, 24}

Where estradiol fits

An estradiol test helps show whether your hormone balance has shifted. It's useful context. It isn't a diagnosis. Gynecomastia can be present even when an estradiol result falls within the laboratory's reference range. ^{22, 23}

A number used to trigger a treatment review is not the same as a proven threshold at which "gyno starts." Current gynecomastia guidance does not establish one estradiol number that predicts breast growth for all men on TRT. The result needs to be read with the exam, medication history, testosterone results, and test method. ^{21, 22, 23}

The practical takeaway: do not use one number to diagnose a lump or choose a medicine.

"My estradiol is high, but I feel fine. Is that a problem?"

A high estradiol result does not automatically mean you need an aromatase inhibitor. Talk it through with your prescriber, who can assess the cause, test reliability, and your full treatment picture. Feeling well is not a reason to ignore an abnormal result, but the result is not a reason to self-treat either. ^{20, 21, 22}

---

Do you need an aromatase inhibitor (anastrozole) on TRT?

Anastrozole is not a routine answer for breast growth on TRT and is not FDA-approved for gynecomastia or male hypogonadism. Its label describes a six-month trial in 80 boys with pubertal gynecomastia that found no statistically significant benefit over placebo. That result is not a controlled trial in adult TRT patients. ^{17, 22, 23}

An aromatase inhibitor, or AI, blocks the enzyme that turns testosterone into estradiol. Anastrozole (brand name Arimidex) is one example. On paper it sounds like the perfect fix: less estrogen, less breast growth. ¹⁷

The evidence tells a different story.

What the treatment evidence shows — and who was studied

Why pushing estradiol too low is its own problem

Estrogen isn't the villain. Men need some. The Endocrine Society notes that estradiol helps prevent fat gain, and that testosterone and estradiol are both needed for sexual function and bone strength. ²⁰

In a one-year analysis of 69 men aged 60 and older with low or low-normal testosterone, spine bone density decreased in the anastrozole group and increased in the placebo group. That study wasn't about men on TRT, but it shows a real trade-off to discuss: lowering estradiol can harm bone density. ²⁶

Is it ever used?

Yes, clinicians sometimes use anastrozole off-label in selected hormone-related situations, and the two TRT case reports above describe benefit. That is much weaker evidence than a controlled trial. ^{21, 27}

The 2019 European Academy of Andrology guideline's limited exception for selected recent, painful gynecomastia concerns tamoxifen, not anastrozole. The 2026 SIAMS guideline recommends against aromatase inhibitors for treating gynecomastia. Any proposed off-label use needs a clinician to explain why it fits your case—not a self-start. ^{22, 23}

---

Does tamoxifen work for gynecomastia from TRT?

Tamoxifen is better studied than anastrozole for gynecomastia in some settings, but evidence specifically for TRT-related cases is limited. In one 48-week prevention trial in men taking bicalutamide for prostate cancer, gynecomastia developed in 10% on tamoxifen, 51% on anastrozole, and 73% on placebo. Using tamoxifen for gynecomastia is off-label and your clinician's call. ^{18, 22, 25}

Tamoxifen works differently from anastrozole. Instead of lowering estrogen everywhere, it blocks estrogen's effect in breast tissue. That's why it belongs to a group called SERMs, short for selective estrogen receptor modulators. ¹⁸

Two honest limits:

• The head-to-head numbers above come from men taking an anti-androgen drug for prostate cancer. That's a very different hormone situation from TRT. The results point in a direction. They don't prove the same numbers for you, and preventing new tissue is not the same as shrinking an existing lump. ²⁵
• It has its own risks. The tamoxifen label includes warnings about blood clots. Any off-label use needs a clinician weighing benefit against risk for you. ¹⁸

We don't list doses on this page. If tamoxifen comes up, your clinician will decide whether it fits and how to monitor it.

What about clomiphene, enclomiphene, and fertility?

Not the same as TRT: clomiphene and enclomiphene are also SERMs, but they are used in some male hormone-care plans to stimulate the body's own testosterone production. They are not testosterone replacement, and they are not interchangeable with tamoxifen for a breast complaint. Clomiphene's male use is off-label; its FDA-approved indication is ovulatory dysfunction in women. The compounded enclomiphene offered by the programs discussed below is not FDA-approved. ^{21, 31, 32, 42}

Exogenous testosterone can suppress sperm production, sometimes severely. Neither infertility nor preserved or restored fertility can be promised for an individual. If you hope to conceive, discuss that before treatment with a urologist or reproductive urologist; the Endocrine Society recommends against starting TRT when near-term fertility is planned. Read does TRT affect fertility. ^{20, 33}

---

Can you prevent gynecomastia on TRT?

No prevention plan is proven to eliminate gynecomastia risk during TRT. Getting checked before you start, choosing a prescriber who follows up, and reporting breast changes help you respond to a problem. They do not guarantee that gland growth will be prevented. ^{1, 20, 22}

What helps:

• Get checked before you start. If you already have breast tenderness or tissue, the AUA says estradiol should be measured first. ²¹
• Choose follow-up, not just a prescription. Ask who reviews new symptoms between scheduled labs and how you will get examined when needed. ^{20, 22}
• Report sore nipples early. Tenderness can be a symptom, but it does not prove gland growth or identify a treatment window. ^{1, 22}
• Don't add non-prescribed steroids or "boosters." Other hormone products can contribute to breast changes and muddy what's causing what. ^{22, 24}

What doesn't have good evidence:

• "Estrogen blocker" supplements sold online. The gynecomastia guidelines cited here do not recommend supplements as proven prevention or treatment. ^{22, 23}
• A preventive AI "just in case." Routine use is not supported by the guidance cited here, and lowering estradiol has its own risks. ^{22, 23, 26}

If a clinic promises "no gyno, guaranteed," ask what evidence supports that for its treatment and patients. Nobody can promise it.

Using testosterone for bodybuilding or without a prescription? This page is about prescribed TRT. Gynecomastia from steroid cycles is a different situation. Talk to a doctor. We don't give cycle or "PCT" advice.

---

When is surgery the answer?

Surgery is an option for long-standing gynecomastia that remains bothersome after the cause has been assessed and managed. It can remove gland tissue, sometimes along with liposuction for surrounding fat. Persistent tissue does not mean surgery is required if observation fits your symptoms and goals. ^{22, 23}

Surgery tends to come up when:

• The tissue has been there many months and isn't shrinking
• It bothers you physically or emotionally after your clinician has looked at the cause
• Assessment has ruled out anything more serious

Two questions worth asking before you book:

1. Is the cause under control? Ask how the underlying cause, duration, and chance of recurrence affect the plan. Guidance supports addressing the cause and allowing observation before surgery, rather than using a fixed 12-month rule for everyone. ^{22, 23}
2. What exactly will be removed — gland, fat, or both? These are different procedures with different recovery.

Ask your insurer and surgeon whether your specific procedure meets the plan's coverage rules, whether prior authorization is needed, and what you would owe. And don't let anyone sell you surgery as the inevitable outcome of a sore nipple.

---

Can you keep taking TRT if you develop gynecomastia?

Gynecomastia does not automatically mean you must stop TRT, but continuing or changing treatment is a medical decision based on your exam, labs, and goals. Breast cancer is a reason not to use testosterone. A suspicious lump needs assessment before it is dismissed as a treatment side effect. ^{1, 20, 21}

Roughly, it plays out three ways:

For other conditions that change the decision, see the contraindication and monitoring sections in our TRT side-effects guide.

If you're getting TRT online, the DEA and HHS have extended certain federal telemedicine prescribing flexibilities through December 31, 2026. The extension allows prescribing without a prior in-person examination only when its conditions are met; it does not remove other federal or state requirements or guarantee that a specific clinic can continue your care. But an online visit can't feel a lump. You may still need an in-person exam. ^{30, 22}

---

What should you bring to your appointment?

Bring a short timeline, a list of everything you take, any lab results you already have, and your questions. The worksheet below organizes all of that for your visit. It doesn't diagnose anything or tell you how to change treatment.

This is a record of your timeline that you can print and hand over. Print it, fill it in, and bring it. Keep the completed version for yourself and your clinician; this page does not ask you to submit it.

Breast changes on TRT: my appointment worksheet

If you have a new hard lump, nipple discharge, a nipple turning inward, or skin dimpling, book the visit now. Don't wait to finish this.

1. What changed

• Date I first noticed it: ______
• Side: ☐ Left ☐ Right ☐ Both
• What I notice: ☐ Sore or sensitive nipple ☐ Puffy look ☐ Disc or lump under the nipple ☐ Lump away from the nipple ☐ Fluid from the nipple ☐ Skin change ☐ Lump in armpit
• Is it changing? ☐ Getting bigger ☐ Same ☐ Getting smaller
• What worries me most: ____________________

2. My treatment timeline

• Testosterone product and format (exact name): ______
• Date I started: ______
• Dates of any dose or format changes: ______
• Other prescriptions, over-the-counter medicines, and supplements: ______

3. Records I already have

• Past breast exams or imaging: ______
• Recent lab reports (with dates and reference ranges): ______

You don't need to buy any tests before your visit.

4. Questions to ask

1. What does the exam suggest, and is there anything else we need to rule out?
2. Could another medicine or health condition be contributing?
3. Which tests, if any, would change the plan — and what would each one tell us?
4. Does my testosterone plan need to change, and what should I do while I wait to hear back?
5. If you suggest an added medicine, is it off-label, what result should I expect, and what risks will we watch for?
6. What follow-up are we agreeing on, and what changes should make me call sooner?

5. Plan agreed with my clinician

• Next steps: ____________________
• Follow-up date: ______
• How to reach the clinic: ______

Print my breast-change questions: use your browser's Print command, then fill in the worksheet above.

---

Choosing or switching TRT clinics? What should you check if gyno worries you?

The useful features are proper testosterone testing, follow-up for new symptoms, and a way to get an in-person breast exam—not an automatic estrogen blocker. Male Excel and Hone publish estradiol in their starting panels; the Taurus Meds pages checked did not identify the panel. Those disclosures do not prove that any program prevents gynecomastia or provides better treatment for it. ^{21, 35, 43, 50}

This section is for two readers: men still choosing where to start TRT, and men whose current clinic won't follow up on breast changes. If you have a red-flag sign right now, skip this. Get examined first.

Affiliate disclosure: TRT Provider Guide has affiliate relationships with Male Excel and Taurus Meds. Hone Health is included for comparison, not as a paid recommendation here. A commercial relationship does not establish better clinical care. See our affiliate disclosure and How We Review TRT Providers.

What we actually verified — October 5, 2026

Sources checked: each provider's public program, pricing, laboratory, and policy pages, including Hone's September 2026 plan documents.

Verified on those pages: the specific published statements summarized below. A statement being visible on a provider's website is not independent verification that every patient receives that service.

Provider-stated, not independently confirmed: lab inclusion, visit format, clinician qualifications, follow-up, medication availability, shipping, billing, refunds, and state coverage.

Not established: each patient's exact drug, manufacturer or compounding pharmacy; the assigned clinician's license; every assay method; complete individualized charges; support response times; breast-exam referral timing; or the medical-record transfer process.

Not done: we did not sign up, see a clinician, or test any service. This is a public-source comparison, not a hands-on review.

How three online TRT programs describe testing and breast-change follow-up

What these price calculations leave out: Male Excel's $120 example is a testosterone-and-thyroid package, not a testosterone-only price or a reason everyone needs thyroid medicine. It describes 60-day medication supplies billed every other month; the annualized subtotal uses 12 monthly equivalents, not a verified 365-day supply. Shipping, extra diagnostic work, and an outside breast exam can change the bill. ³⁶

Hone lists follow-up labs, consultations, and shipping as included in Premium, but medication is separate. Its testosterone sales page still advertises a starting monthly price while the newer Premium page uses a per-vial price. Ask for the number of vials and total annual medication charge in your written quote. The $25 Basic plan is not a TRT plan; Hone also lists a $135 Plus hormone-treatment tier, so Premium is not its only hormone-care option. ^{42, 44, 48}

Taurus's $1,837 is only the offer-page arithmetic. Do not assume that its separate $17.99 recurring charge applies—or is waived—without the purchase terms. Required follow-up labs, shipping, the exact medicine, and the applicable refund terms also need written confirmation. These subtotals cannot establish which program will be cheapest for you. ^{50, 51, 52}

Male Excel: an at-home starting panel, not a substitute for a breast exam

Male Excel includes estradiol in its starting test kit. Its stated default is no routine estrogen blockers, while its own article allows a limited blocker course for breast swelling when a clinician thinks it's warranted. That does not establish lower gynecomastia risk. ^{35, 39}

The trade-off you should know about: Male Excel does not use a traditional lab draw for its starting kit. Its first test is an at-home blood-spot kit you mail back. If a needle-in-the-arm draw at a lab matters to you, Hone's Premium plan publishes that option. But a convenient blood-spot test does not replace an examination or prove that the required repeat serum testosterone testing has been completed. ^{35, 43, 20}

Before you pay, know this:

• Its terms generally say fees are final, but its homepage advertises a conditional guarantee of three monthly membership fees. Cancellation and a guarantee claim are different processes; ask for the terms that apply to you. ^{37, 38}
• Its program describes compounded testosterone treatment. Compounded preparations are not FDA-approved. Ask which product and dispensing pharmacy you would receive. ^{37, 31}
• Its FAQ lists 11 excluded states, shown in the table. ⁴⁰

Choose a different starting point if: you have a red-flag breast sign (get examined in person first), need a venous diagnostic draw, live in an excluded state, or are trying to conceive soon (start with does TRT affect fertility). A preference for an FDA-approved medicine also needs a prescriber and pharmacy that confirm that exact product—not an assumption based on the word "cypionate."

Does the at-home test sound convenient? Before paying, ask how a new breast symptom will be examined and how repeat diagnostic testing is handled. Use the appointment questions above to get those answers in writing. A test doesn't guarantee a prescription.

Hone Health: a published at-lab panel and video consultation

Hone lists estradiol in its Premium at-lab panel, with follow-up testing at months 3, 6, 9, and 12 in the first year. Its Premium description includes an initial live physician video consultation. Those are concrete service disclosures, not proof of better gynecomastia outcomes. ^{42, 43}

What to weigh:

• Hone sells anastrozole, and its product page lists reducing gynecomastia as a benefit. The adult TRT evidence above does not support a promise of reliable benefit. Its marketing should not replace an examination and a discussion of the limited evidence. ^{47, 17, 27}
• Some Hone medications are compounded and not FDA-approved, which Hone discloses. Ask which product you'd receive. ^{42, 31}
• Membership and medicine are billed separately. Its policy allows some refunds, but no partial-month membership refund; canceling one subscription does not cancel the other. ⁴⁶

Want a lab draw and video visits? Compare those services with a local practice that can examine your chest. Read online TRT vs. a local clinic before choosing based on the lab panel alone.

Taurus Meds

Taurus Meds does publish a TRT offer, but the pages checked do not identify its estradiol panel or monitoring schedule. We can't recommend it for gynecomastia concerns specifically. If you're considering it, ask whether estradiol is tested when indicated and how breast symptoms get examined before you pay. ^{50, 51}

The unresolved details matter: the offer says no membership fees while the terms list a recurring fee unless purchase terms say otherwise. The offer's formulation table also mixes gel and injection-style descriptions. Neither uncertainty should be resolved by guessing what medicine or bill you will receive. Ask for the exact formulation, FDA-approved or compounded status, dispensing pharmacy, full charges, and applicable cancellation and refund terms in writing. ^{50, 51, 52}

When an in-person clinic is the better route

An online visit can't examine your chest by touch. In-person care is the better start if you:

• Have any red-flag sign
• Already have breast tissue and haven't had it assessed before starting TRT
• Have a history of breast cancer
• Have long-standing, firm tissue you may want surgery for

Primary care can do the exam and coordinate imaging. An endocrinologist or urologist can manage the hormone side. A breast specialist or surgeon may be needed for suspicious or persistent findings. ^{20, 22, 28}

Before transferring care, ask who will handle refills during the handoff, how both clinicians will receive your labs and examination results, and whether there are record-release fees. Do not assume a subscription change transfers your medical records or gives the new clinic authority to prescribe.

---

How did we check this page?

This page compares 16 testosterone label records, prescribing information for the other medicines discussed, specialty guidance including the 2026 SIAMS guideline, original studies, and dated provider disclosures. The source check was completed October 5, 2026; archived records are labeled as historical. This is editorial research, not a clinical review or an examination.

Our method:

• Labels first. The testosterone incidence figures come from the cited label tables, with study size and length kept attached where reported. The anastrozole and tamoxifen trial populations and outcomes are identified separately.
• No pooling. We didn't combine numbers from different studies into one "TRT rate," because that would be misleading.
• Population labels. When evidence comes from a different group — boys in puberty, men on prostate-cancer drugs, older men not on TRT — we say so.
• Four kinds of claims, kept separate. Verified facts, provider-stated facts, customer-experience signals, and our editorial judgments. That's the core of How We Review TRT Providers.
• Dated. Prices, policies, and rules change. The date above records this source check; historical label revision dates are not changed to make them appear new.

Found something out of date? Send the source and the correction through our contact page. For a health concern, contact your clinician rather than waiting for an editorial response.

---

What else should you know about TRT and gynecomastia?

Breast tenderness, a hormone result, and gland growth are different findings. These answers help frame the next question for your clinician; none can identify a lump without assessment. ^{1, 22}

Does TRT cause gynecomastia?

It can. The 16 label records above recognize gynecomastia. Selected gel treatment groups reported 0–3%; the Testim/Vogelxo placebo table reports 0%. Those study-specific figures are not a risk estimate for every man or treatment format. ^{1, 3, 4}

How soon after starting TRT can gyno show up?

There's no set week when it starts or stops. A label finding that estradiol rose within 30 days is not evidence that gynecomastia starts then. Report new breast changes whenever they appear, including after a treatment change. ^{1, 22}

Will gyno from TRT go away on its own?

Recent tissue may settle after the cause is addressed, but the labels warn that gynecomastia can persist. Long-standing, fibrous tissue responds less well to medicine. Duration guides the discussion; it is not a guaranteed deadline or recovery forecast. ^{1, 22, 23}

Does anastrozole get rid of gyno?

Evidence specifically for adult TRT-related gynecomastia is limited, including two positive case reports. The placebo-controlled trial on the anastrozole label involved boys in puberty and did not show a statistically significant benefit. It is not FDA-approved for gynecomastia; ask your clinician before taking it. ^{17, 27}

Is tamoxifen better than anastrozole for gyno?

In the cited bicalutamide prevention trial, gynecomastia developed in 10% on tamoxifen vs. 51% on anastrozole. But those men were taking a prostate-cancer drug, and tamoxifen is off-label for gynecomastia. The trial does not establish the same benefit for treating existing breast tissue during TRT. ^{18, 25}

What estradiol level causes gyno?

There is no validated estradiol cutoff that diagnoses gynecomastia or predicts it for every TRT patient. A result within the laboratory's range does not exclude gland growth. The exam and full clinical picture matter. ^{22, 23}

Can low testosterone cause gynecomastia?

Yes. The Endocrine Society lists breast discomfort and gynecomastia as possible signs of low testosterone. Some men have breast tissue before TRT. Breast growth alone is not a diagnosis: compatible symptoms or signs and consistently low results on repeat early-morning testing are required. ²⁰

Do injections cause more gyno than gel?

The label data on this page cannot rank injection versus gel risk. The enanthate and Testopel labels retain "frequently develops" without a percentage, while selected gels report trial rates. Those different kinds of evidence cannot establish a safer format for your chest. ^{1, 8, 9}

Does compounded testosterone cream cause gynecomastia?

It is possible, but the commercial gel rates above cannot be used to predict a compounded cream's risk. Compounded testosterone preparations are not FDA-approved, and this comparison does not provide an FDA-reviewed product-specific incidence estimate for them. ^{22, 31}

Is it gyno or just chest fat?

Gynecomastia often feels like a firm or rubbery disc under the nipple. Chest fat is softer and spread out. A clinician's exam helps tell them apart; a new or unclear lump may need further testing. ^{22, 24}

Can gynecomastia be breast cancer?

Gynecomastia itself is not cancer. But breast cancer in men, while rare, can look like a lump. A hard, fixed, one-sided lump, nipple discharge, a nipple turning inward, or skin dimpling needs prompt clinical assessment. ^{24, 28}

Should I stop TRT if I get gyno?

Not on your own. Contact your prescriber and ask what to do while the breast change is assessed. Gynecomastia does not automatically require stopping TRT, but whether to continue or change treatment is a medical decision. ^{1, 21}

Do sore nipples on TRT mean gyno?

Not always. Breast pain was tracked separately from gynecomastia in the AndroGel trials. Report new tenderness, but do not use it by itself to diagnose gland growth. ¹

Will losing weight fix gyno?

Weight loss can help chest fat, but it is not an established way to remove breast gland tissue. A chest can contain both fat and gland, so a change in size does not settle the diagnosis. ²⁴

---

What is the bottom line on TRT and gynecomastia?

TRT can cause breast gland growth, but a sore nipple is not a diagnosis and a study percentage is not your personal risk. The next step is to get the change assessed, then discuss the cause and options—not to add an estrogen blocker on your own. ^{1, 22, 28}

• It's a real labeled effect. Selected gel trial groups reported 0–3%, not a universal TRT rate.
• Raise new changes early. Prompt assessment does not mean rushing into medicine or surgery.
• Red flags need an exam. Don't wait on a hard, fixed lump or nipple discharge.
• An estrogen blocker isn't the automatic answer. Adult TRT evidence is limited; the cause and clinical findings come first.

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

Keep reading: TRT side effects and monitoring · Does TRT affect fertility? · Online TRT vs. a local clinic · Signs of low testosterone

---

Where can you check the sources?

The sources below separate product labeling, clinical evidence, and provider statements. They were accessed for this review on October 5, 2026; publication or label revision dates are shown where needed to distinguish current records from archives.

Testosterone product labels

1. AndroGel 1% prescribing information, revised October 2025. Sections 5.11, 6.1 (Tables 2–3), and 12.3.

2. AndroGel 1.62% prescribing information. Gynecomastia warning, postmarketing reports, and estradiol pharmacokinetics.

3. Testim prescribing information, revised July 2025. Sections 5.11 and 6.1, including the 90-day trial population and Table 1.

4. Vogelxo prescribing information. Gynecomastia warning and 90-day trial data.

5. Fortesta archived FDA prescribing information, December 2010. Sections 5.8 and 6.1. Historical label, not a current availability claim.

6. Androderm archived prescribing information, revised May 2020. Section 5.10 and patient information. Historical label, not a current availability claim.

7. Depo-Testosterone prescribing information. Warnings and adverse reactions.

8. Hikma testosterone enanthate prescribing information, revised June 2025. Warnings and adverse reactions.

9. Testopel prescribing information, revised July 2025. Warnings and contraindications.

10. Xyosted prescribing information. Gynecomastia warning and clinical-trial adverse-reaction tables.

11. Aveed prescribing information. Gynecomastia warning and 84-week trial adverse reactions.

12. Jatenzo prescribing information and Medication Guide. Gynecomastia warning.

13. Tlando prescribing information, revised February 2026. Gynecomastia warning.

14. Kyzatrex prescribing information, revised August 2026. Gynecomastia warning.

15. Natesto prescribing information. Gynecomastia warning.

16. Azmiro prescribing information. Section 5.11, Gynecomastia, and adverse reactions.

Other medicines, guidelines, and original studies

17. Arimidex (anastrozole) prescribing information, revised December 2025. Indications and section 8.4: pubertal gynecomastia trial.

18. Tamoxifen citrate prescribing information. Indications and thromboembolic warnings.

19. Evista (raloxifene) prescribing information. Section 5.10: use in men.

20. Bhasin S, et al. Endocrine Society clinical practice guideline: Testosterone Therapy in Men With Hypogonadism. JCEM. 2018. Diagnosis, monitoring, contraindications, and testosterone/estradiol physiology.

21. Mulhall JP, et al. American Urological Association guideline: Evaluation and Management of Testosterone Deficiency. Journal of Urology. 2018. Statements 2–3, 9, 16, 23, and 27.

22. Kanakis GA, et al. EAA clinical practice guidelines—gynecomastia evaluation and management. Andrology. 2019. Evaluation, watchful waiting, medicines, and surgery.

23. SIAMS clinical practice guidelines: Management of gynecomastia in adolescence and adults. Journal of Endocrinological Investigation. Published June 8, 2026. Clinical evaluation and management recommendations.

24. Endocrine Society. Gynecomastia: patient information on causes, examination, testing, and treatment.

25. Boccardo F, et al. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. JCO. 2005;23:808–815. Author-shared article; DOI: 10.1200/JCO.2005.12.013.

26. Burnett-Bowie SAM, et al. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. JCEM. 2009. One-year randomized trial.

27. Rhoden EL, Morgentaler A. Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole. International Journal of Impotence Research. 2004. Two case reports, not a controlled trial.

Cancer information, prescribing rules, and reader language

28. National Cancer Institute. Male Breast Cancer. Symptoms and diagnostic assessment.

29. American Cancer Society. Key Statistics for Breast Cancer in Men. Revised January 13, 2026.

30. DEA and HHS. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. Federal Register, December 31, 2025; effective through December 31, 2026. 21 CFR 1307.41.

31. FDA. Compounding and the FDA: Questions and Answers. Approval, safety, effectiveness, and quality distinctions.

32. Clomid (clomiphene citrate) prescribing information. Approved indication for ovulatory dysfunction.

33. AUA/ASRM. Diagnosis and Treatment of Infertility in Men, Part II. Exogenous testosterone and sperm production; fertility-directed care.

34. Reddit, r/trt. “Gyno on trt.” Original reader-language quotation only; not medical evidence or a provider testimonial.

Provider disclosures

35. Male Excel. At-home hormone test: advertised fee, blood-spot collection, and listed markers.

36. Male Excel. HRT costs: consultation, membership, starting injection-and-thyroid package, billing, and shipping.

37. Male Excel. Public program information: follow-up, compounded treatment, and conditional membership-fee guarantee.

38. Male Excel. Terms and conditions: payment, cancellation, and refund limitations.

39. Male Excel. Estrogen blockers article. Provider-stated approach, not independent treatment evidence.

40. Male Excel. FAQ: state exclusions and treatment descriptions.

41. Male Excel. TRT online program: clinician access, treatment formats, and monitoring claims.

42. Hone Health. Premium Membership: Full Clinical Insight for Men. Updated September 29, 2026. Fees, medication units, live consultation, shipping, and included services.

43. Hone Health. Men’s Lab Schedule on the Premium Plan. Updated September 9, 2026. Baseline, confirmatory, and follow-up tests.

44. Hone Health. Membership Overview: Compare Basic, Plus & Premium Plans. Basic is not a hormone-treatment plan.

45. Hone Health. Service Availability by State (2026). Updated September 4, 2026. Plan-specific availability.

46. Hone Health. Order Cancellation and Refund Policy. Updated August 31, 2026. Separate membership and prescription cancellation.

47. Hone Health. Anastrozole product page. Advertising claim checked against clinical evidence, not used as medical authority.

48. Hone Health. Testosterone product page. Advertised starting monthly price, compared with the newer per-vial Premium disclosure.

49. Hone Health. How it works. Public program and laboratory-access description.

50. Taurus Meds. Testosterone offer: $49 testing/consultation, $149 monthly offer, formulation descriptions, and guarantee wording.

51. Taurus Meds. Terms of use: recurring membership charge, clinical network, pharmacy disclosures, and refund terms.

52. Taurus Meds. Subscription Services Cancellation and Refund Policy. Updated February 28, 2026. Notice period and refund limitations.

53. Taurus Meds. Homepage. Public service and medication claims.